http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101577189-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-79 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-015 |
| filingDate | 2014-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101577189-B1 |
| titleOfInvention | Compositions for preventing or treating allergy containing? -cubebenoate as an active ingredient |
| abstract | The present invention relates to a composition for preventing or treating allergy comprising alpha -cubebenoate as an active ingredient, and more particularly to a composition for preventing or treating allergy comprising alpha -cubebenoate isolated from Omija By inhibiting β-hexosamidase activity and mast cell intracellular [Ca 2 + ] i -induced mucin secretion in mast cells exposed to the antigen, it is possible to inhibit degranulation of inflammatory mediators that induce allergy Therefore, the composition containing? -Cubebenoate according to the present invention as an active ingredient can effectively prevent or treat an allergic disease. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180013483-A |
| priorityDate | 2014-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.